Swapnil Jatinbhai Shah
Fortuna: 84 M $ al 30/09/2026
Fortuna: 84 M $ al 30/09/2026
Mr. Swapnil Jatinbhai Shah is a Managing Director & Executive Director at Senores Pharmaceuticals Ltd. and a Non-Executive Chairman at Remus Pharmaceuticals Ltd. He is on the Board of Directors at Senores Pharmaceuticals Ltd., Aelius Projects LLP, Calypso Hospitality LLP, Espee Therapeutics LLP, Havix Group, Inc., Ratnagene Lifescience Pvt Ltd., Ratnatris Pharmaceuticals Pvt Ltd., Relius Lifesciences Pvt Ltd., Renosen Pharmaceuticals Pvt Ltd., Senores Pharmaceuticals, Inc. and Sumer Enterprises LLP.
He received his undergraduate degree from Gujarat University, an undergraduate degree from Nirma University and an MBA from Hofstra University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/03/2026 | 5.848.031 ( 12,7 % ) | 84 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| REMUS PHARMACEUTICALS LIMITED | Presidente | 21/09/2015 |
| SENORES PHARMACEUTICALS LIMITED | Director Ejecutivo | 15/10/2021 |
Relius Lifesciences Pvt Ltd. | Director/Miembro de la Junta | - |
Renosen Pharmaceuticals Pvt Ltd. | Director/Miembro de la Junta | - |
Ratnatris Pharmaceuticals Pvt Ltd.
Ratnatris Pharmaceuticals Pvt Ltd. Ratnatris Pharmaceuticals Pvt Ltd. is a pharmaceutical company specializing in the development, manufacturing, and supply of affordable, high-quality generic medicines and innovative formulations. Ratnatris operates seven advanced manufacturing facilities, including a US FDA-approved plant in the USA, and produces oral solids, parenterals, beta lactams, and cephalosporins. The company is based in Ahmedabad, India. The Indian company offers a broad portfolio of over 500 commercial products across multiple therapeutic categories, including anaesthetics, anti-infectives, cardiovascular, central nervous system, and nutritional supplements. The company focuses on continuous innovation, developing complex generics supported by robust R&D, clinical trials, regulatory compliance, and intellectual property expertise. Ratnatris maintains stringent quality standards aligned with WHO cGMP and ISO 9001:2008, and holds certifications from various national health authorities. | Director/Miembro de la Junta | - |
Ratnagene Lifescience Pvt Ltd. | Director/Miembro de la Junta | - |
Espee Therapeutics LLP | Director/Miembro de la Junta | - |
Aelius Projects LLP | Director/Miembro de la Junta | - |
Calypso Hospitality LLP | Director/Miembro de la Junta | - |
| ░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 15 |
|---|---|
Hofstra University
Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gujarat University
Gujarat University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nirma University
Nirma University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Havix Group, Inc.
Havix Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Senores Pharmaceuticals Pvt Ltd.
Senores Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and generic medicines | Health Technology |
Remus Pharmaceuticals Ltd.
Remus Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products with expertise in neurology, cardiology & gastroenterology | Health Technology |
Senores Pharmaceuticals, Inc.
Senores Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Health Technology |
Ratnagene Lifescience Pvt Ltd. | |
Relius Lifesciences Pvt Ltd. | |
Ratnatris Pharmaceuticals Pvt Ltd.
Ratnatris Pharmaceuticals Pvt Ltd. Ratnatris Pharmaceuticals Pvt Ltd. is a pharmaceutical company specializing in the development, manufacturing, and supply of affordable, high-quality generic medicines and innovative formulations. Ratnatris operates seven advanced manufacturing facilities, including a US FDA-approved plant in the USA, and produces oral solids, parenterals, beta lactams, and cephalosporins. The company is based in Ahmedabad, India. The Indian company offers a broad portfolio of over 500 commercial products across multiple therapeutic categories, including anaesthetics, anti-infectives, cardiovascular, central nervous system, and nutritional supplements. The company focuses on continuous innovation, developing complex generics supported by robust R&D, clinical trials, regulatory compliance, and intellectual property expertise. Ratnatris maintains stringent quality standards aligned with WHO cGMP and ISO 9001:2008, and holds certifications from various national health authorities. | |
Calypso Hospitality LLP | |
Sumer Enterprises LLP | |
Renosen Pharmaceuticals Pvt Ltd. | |
Espee Therapeutics LLP | |
Aelius Projects LLP |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.